84 related articles for article (PubMed ID: 19995858)
1. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
[TBL] [Abstract][Full Text] [Related]
2. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?
Çandereli ZÖ; Arslan T; Özdamar Ö; Yay M; Karaçayli Ü; Şişman-Kitapçi N; Adesanya A; Aksoy A; Belem JMFM; Taş MN; Cardin NB; Sacoor S; Gokani B; Armağan B; Sari A; Bozca BC; Tekgöz E; Desai P; Temiz Karadağ D; Badak SÖ; Tecer D; Bibi A; Yildirim A; Bes C; Şahin A; Erken E; Cefle A; Çinar M; Yilmaz S; Alpsoy E; Boyvat A; Şenel S; Yaşar Bilge Ş; Kaşifoğlu T; Karadağ Ö; Aksu K; Keser G; Alibaz-Öner F; Inanç N; Ergun T; Madanat W; de Souza AWS; Direskeneli H; Fortune F; Mumcu G
Clin Exp Rheumatol; 2023 Oct; 41(10):2078-2086. PubMed ID: 37902270
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes of Mexican Patients With Behçet's Syndrome.
Hinojosa-Azaola A; Ramírez-Mulhern I; Figueroa-Pariente A; Martín-Nares E
J Clin Rheumatol; 2023 Sep; 29(6):275-280. PubMed ID: 37170407
[TBL] [Abstract][Full Text] [Related]
4. Clinical phenotypes of adult-onset Behçet's syndrome: a comprehensive cross-sectional study in China.
She CH; Hu D; Zou J; Bao HF; Shen Y; Cai JF; Ye JF; Luo D; Jian LL; Ma HF; Hou CC; Chen Y; Guan JL
Clin Rheumatol; 2024 Jul; 43(7):2261-2271. PubMed ID: 38724819
[TBL] [Abstract][Full Text] [Related]
5. Disease and Treatment-Specific Complications of Behçet Syndrome.
Esatoglu SN; Ozguler Y; Hatemi G
Curr Rheumatol Rep; 2024 Jan; 26(1):1-11. PubMed ID: 37995045
[TBL] [Abstract][Full Text] [Related]
6. A case of Behçet syndrome presenting with acute coronary syndrome.
Akkuzu G; Erdoğan A; Moustafa C; Deniz R; Özgür DS; Karaalioğlu B; Yıldırım F; Bes C
Int J Rheum Dis; 2024 Jan; 27(1):e14852. PubMed ID: 37522652
[TBL] [Abstract][Full Text] [Related]
7. Behçet's syndrome in pregnancy.
Martineau M; Haskard DO; Nelson-Piercy C
Obstet Med; 2010 Mar; 3(1):2-7. PubMed ID: 27582833
[TBL] [Abstract][Full Text] [Related]
8. The mediator role of treatment response on oral health related quality of life in Behçet's syndrome.
Altıngöz EN; Yenisoy Y; Kapusuz A; Abacar K; Şişman-Kitapçı N; Yay M; Karacaylı U; Alibaz-Öner F; İnanç N; Ergun T; Fortune F; Direskeneli H; Mumcu G
Med Oral Patol Oral Cir Bucal; 2023 Dec; 29(3):e350-5. PubMed ID: 38150605
[TBL] [Abstract][Full Text] [Related]
9. Behçet's syndrome: a critical digest of the 2013-2014 literature.
Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S112-22. PubMed ID: 25268667
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of azathioprine in Behçet's syndrome.
Yazici H; Pazarli H; Barnes CG; Tüzün Y; Ozyazgan Y; Silman A; Serdaroğlu S; Oğuz V; Yurdakul S; Lovatt GE
N Engl J Med; 1990 Feb; 322(5):281-5. PubMed ID: 2404204
[TBL] [Abstract][Full Text] [Related]
11. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.
Mizuki Y; Horita N; Horie Y; Takeuchi M; Ishido T; Mizuki R; Kawagoe T; Shibuya E; Yuda K; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Fukumoto T; Kurosawa M; Kitaichi N; Takeno M; Kaneko T; Mizuki N
Mod Rheumatol; 2020 Jul; 30(4):708-714. PubMed ID: 31386589
[No Abstract] [Full Text] [Related]
12. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease.
Jung YS; Hong SP; Kim TI; Kim WH; Cheon JH
J Clin Gastroenterol; 2012; 46(5):e38-45. PubMed ID: 22298088
[TBL] [Abstract][Full Text] [Related]
13. Mortality in Behçet's disease.
Saadoun D; Wechsler B; Desseaux K; Le Thi Huong D; Amoura Z; Resche-Rigon M; Cacoub P
Arthritis Rheum; 2010 Sep; 62(9):2806-12. PubMed ID: 20496419
[TBL] [Abstract][Full Text] [Related]
14. Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey.
Demiroğlu H; Barişta I; Dündar S
Ophthalmology; 1997 Apr; 104(4):701-5. PubMed ID: 9111266
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of early immunomodulatory treatment on ocular involvement in Behcet's disease: Historical cohort of 1166 patients.
Tehrani-Banihashemi A; Faezi ST; Solaymani-Dodaran M; Mohammadi F; Shahram F; Paragomi P; Moradi K; Davatchi F
Heliyon; 2023 Sep; 9(9):e19981. PubMed ID: 37809442
[TBL] [Abstract][Full Text] [Related]
16. Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis.
Kim D; Nakamura K; Kaneko F; Alpsoy E; Bang D
Front Med (Lausanne); 2022; 9():987393. PubMed ID: 36530905
[TBL] [Abstract][Full Text] [Related]
17. Mucocutaneous Manifestations of Behçet's Disease.
Nakamura K; Tsunemi Y; Kaneko F; Alpsoy E
Front Med (Lausanne); 2020; 7():613432. PubMed ID: 33598466
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51.
Ryu HJ; Seo MR; Choi HJ; Baek HJ
Korean J Intern Med; 2018 Sep; 33(5):1025-1031. PubMed ID: 28073242
[TBL] [Abstract][Full Text] [Related]
19. Colchicine for prevention of cardiovascular events.
Hemkens LG; Ewald H; Gloy VL; Arpagaus A; Olu KK; Nidorf M; Glinz D; Nordmann AJ; Briel M
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011047. PubMed ID: 26816301
[TBL] [Abstract][Full Text] [Related]
20. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.
Hatemi G; Ozguler Y; Direskeneli H; Mahr A; Gul A; Levi V; Aydin SZ; Mumcu G; Sertel-Berk O; Stevens RM; Yazici H; Merkel PA
J Rheumatol; 2015 Dec; 42(12):2436-41. PubMed ID: 26373563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
